Enara Bio
An Oxford-based biotech company developing “cutting-edge” cancer treatments
Oxford, UKwww.enarabio.com ↗
Total raised
€29M
€29,481,400
Funding rounds
1
Investors
3
distinct backers
Active since
2024-10
latest 2024-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood52
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-10-03 | Series B | €29M | Francis Crick Institute,M Ventures,Pfizer | View deal → |